These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15220218)

  • 1. The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes.
    D'Adamo M; Perego L; Cardellini M; Marini MA; Frontoni S; Andreozzi F; Sciacqua A; Lauro D; Sbraccia P; Federici M; Paganelli M; Pontiroli AE; Lauro R; Perticone F; Folli F; Sesti G
    Diabetes; 2004 Jul; 53(7):1905-10. PubMed ID: 15220218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects.
    Sesti G; Cardellini M; Marini MA; Frontoni S; D'Adamo M; Del Guerra S; Lauro D; De Nicolais P; Sbraccia P; Del Prato S; Gambardella S; Federici M; Marchetti P; Lauro R
    Diabetes; 2003 May; 52(5):1280-3. PubMed ID: 12716765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet.
    Sesti G; Perego L; Cardellini M; Andreozzi F; Ricasoli C; Vedani P; Guzzi V; Marchi M; Paganelli M; Ferla G; Pontiroli AE; Hribal ML; Folli F
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5064-9. PubMed ID: 15985484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of the -866A/55Val/Ins haplotype in the uncoupling protein 2 (UCP2) gene is associated with decreased UCP2 gene expression in human retina.
    de Souza BM; Assmann TS; Kliemann LM; Marcon AS; Gross JL; Canani LH; Crispim D
    Exp Eye Res; 2012 Jan; 94(1):49-55. PubMed ID: 22134120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The frequent UCP2 -866G>A polymorphism protects against insulin resistance and is associated with obesity: a study of obesity and related metabolic traits among 17 636 Danes.
    Andersen G; Dalgaard LT; Justesen JM; Anthonsen S; Nielsen T; Thørner LW; Witte D; Jørgensen T; Clausen JO; Lauritzen T; Holmkvist J; Hansen T; Pedersen O
    Int J Obes (Lond); 2013 Feb; 37(2):175-81. PubMed ID: 22349573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans.
    Krempler F; Esterbauer H; Weitgasser R; Ebenbichler C; Patsch JR; Miller K; Xie M; Linnemayr V; Oberkofler H; Patsch W
    Diabetes; 2002 Nov; 51(11):3331-5. PubMed ID: 12401727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion.
    Wang H; Chu WS; Lu T; Hasstedt SJ; Kern PA; Elbein SC
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E1-7. PubMed ID: 12915397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The common -866G/A polymorphism in the promoter region of the UCP-2 gene is associated with reduced risk of type 2 diabetes in Caucasians from Italy.
    Bulotta A; Ludovico O; Coco A; Di Paola R; Quattrone A; Carella M; Pellegrini F; Prudente S; Trischitta V
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1176-80. PubMed ID: 15562023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional polymorphisms of UCP2 and UCP3 are associated with a reduced prevalence of diabetic neuropathy in patients with type 1 diabetes.
    Rudofsky G; Schroedter A; Schlotterer A; Voron'ko OE; Schlimme M; Tafel J; Isermann BH; Humpert PM; Morcos M; Bierhaus A; Nawroth PP; Hamann A
    Diabetes Care; 2006 Jan; 29(1):89-94. PubMed ID: 16373902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased adiposity and reduced adipose tissue mRNA expression of uncoupling protein-2 in first-degree relatives of type 2 diabetic patients: evidence for insulin stimulation of UCP-2 and UCP-3 gene expression in adipose tissue.
    Pedersen SB; Nyholm B; Kristensen K; Nielsen MF; Schmitz O; Richelsen B
    Diabetes Obes Metab; 2005 Jan; 7(1):98-105. PubMed ID: 15642081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous adipose tissue expression of tumour necrosis factor-alpha is not associated with whole body insulin resistance in obese nondiabetic or in type-2 diabetic subjects.
    Koistinen HA; Bastard JP; Dusserre E; Ebeling P; Zegari N; Andreelli F; Jardel C; Donner M; Meyer L; Moulin P; Hainque B; Riou JP; Laville M; Koivisto VA; Vidal H
    Eur J Clin Invest; 2000 Apr; 30(4):302-10. PubMed ID: 10759878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The -866G/A polymorphism in the promoter of the UCP2 gene is associated with risk for type 2 diabetes and with decreased insulin levels.
    Gomathi P; Samarth AP; Raj NBAJ; Sasikumar S; Murugan PS; Nallaperumal S; Selvam GS
    Gene; 2019 Jun; 701():125-130. PubMed ID: 30910560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between the UCP2 -866 G>A polymorphism, diabetes, and beta-blocker use among patients with acute coronary syndromes.
    Beitelshees AL; Finck BN; Leone TC; Cresci S; Wu J; Province MA; Fabbrini E; Kirk E; Zineh I; Klein S; Spertus JA; Kelly DP
    Pharmacogenet Genomics; 2010 Apr; 20(4):231-8. PubMed ID: 20145583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mRNA expression levels of uncoupling proteins 1 and 2 in mononuclear cells from patients with metabolic disorders: obesity and type 2 diabetes mellitus.
    Margaryan S; Witkowicz A; Partyka A; Yepiskoposyan L; Manukyan G; Karabon L
    Postepy Hig Med Dosw (Online); 2017 Oct; 71(0):895-900. PubMed ID: 29151065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study of the -866G/A UCP2 gene promoter polymorphism with type 2 diabetes and obesity in a Tehran population: a case control study.
    Heidari J; Akrami SM; Heshmat R; Amiri P; Fakhrzadeh H; Pajouhi M
    Arch Iran Med; 2010 Sep; 13(5):384-90. PubMed ID: 20804304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncoupling protein 2 promoter polymorphism -866G/A affects peripheral nerve dysfunction in Japanese type 2 diabetic patients.
    Yamasaki H; Sasaki H; Ogawa K; Shono T; Tamura S; Doi A; Sasahara M; Kawashima H; Nakao T; Furuta H; Nishi M; Nanjo K
    Diabetes Care; 2006 Apr; 29(4):888-94. PubMed ID: 16567833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common polymorphism of uncoupling protein 2 gene is associated with hypertension.
    Ji Q; Ikegami H; Fujisawa T; Kawabata Y; Ono M; Nishino M; Ohishi M; Katsuya T; Rakugi H; Ogihara T
    J Hypertens; 2004 Jan; 22(1):97-102. PubMed ID: 15106800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The common G-866A polymorphism of the UCP2 gene and survival in diabetic patients following myocardial infarction.
    Palmer BR; Devereaux CL; Dhamrait SS; Mocatta TJ; Pilbrow AP; Frampton CM; Skelton L; Yandle TG; Winterbourn CC; Richards AM; Montgomery HE; Cameron VA
    Cardiovasc Diabetol; 2009 Jun; 8():31. PubMed ID: 19527523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of mRNAs encoding uncoupling proteins in human skeletal muscle: effects of obesity and diabetes.
    Bao S; Kennedy A; Wojciechowski B; Wallace P; Ganaway E; Garvey WT
    Diabetes; 1998 Dec; 47(12):1935-40. PubMed ID: 9836527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis.
    Fares R; Petta S; Lombardi R; Grimaudo S; Dongiovanni P; Pipitone R; Rametta R; Fracanzani AL; Mozzi E; Craxì A; Fargion S; Sesti G; Valenti L
    Liver Int; 2015 May; 35(5):1574-80. PubMed ID: 25351290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.